NeuroImage: Clinical (Jan 2019)

Gray matter structural covariance networks changes along the Alzheimer's disease continuum

  • Kaicheng Li,
  • Xiao Luo,
  • Qingze Zeng,
  • Peiyu Huang,
  • Zhujing Shen,
  • Xiaojun Xu,
  • Jingjing Xu,
  • Chao Wang,
  • Jiong Zhou,
  • Minming Zhang

Journal volume & issue
Vol. 23

Abstract

Read online

Alzheimer's disease (AD) has a long neuropathological accumulation phase before the onset of dementia. Such AD neuropathological deposition between neurons impairs the synaptic communication, resulting in networks disorganization. Our study aimed to explore the evolution patterns of gray matter structural covariance networks (SCNs) along AD continuum. Based on the AT(N) (i.e., Amyloid/Tau/Neurodegeneration) pathological classification system, we classified subjects into four groups using cerebrospinal fluid amyloid-beta1–42 (A) and phosphorylated tau protein181 (T). We identified 101 subjects with normal AD biomarkers (A-T-), 40 subjects with Alzheimer's pathologic change (A + T−), 101 subjects with biological AD (A + T+) and 91 AD with dementia (demented subjects with A + T+). We used four regions of interest to anchor default mode network (DMN, medial temporal subsystem and midline core subsystem), salience network (SN) and executive control network (ECN). Finally, we used a multi-regression model-based linear-interaction analysis to assess the SCN changes. Along the disease progression, DMN and SN showed increased structural association at the early stage while decreased structural association at the late stage. Moreover, ECN showed progressively increased structural association as AD neuropathological profiles progress. In conclusion, this study found the dynamic trajectory of SCNs changes along the AD continuum and support the network disconnection hypothesis underlying AD neuropathological progression. Further, SCN may potentially serve as an effective AD biomarker. Keywords: Alzheimer's disease continuum, Gray matter structural covariance, AT(N) classification system, CSF, Tau protein, Amyloid